Preliminary comments on proteasome inhibition and cardiovascular disease Friedrich C. Luft Clinical Implications 18 June 2009 Pages: 749 - 751
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation Olaf HoffmannFrauke ZippJoerg R. Weber Review 17 May 2009 Pages: 753 - 763
Functions of lipid raft membrane microdomains at the blood–brain barrier Aurore Dodelet-DevillersRomain CayrolAlexandre Prat Review 30 May 2009 Pages: 765 - 774
Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps Maren von Köckritz-BlickwedeVictor Nizet Review Open access 16 May 2009 Pages: 775 - 783
The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy Shin-ichi OkaTetsuro AgoJunichi Sadoshima Review 08 May 2009 Pages: 785 - 791
Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system Antje LudwigMandy FechnerKarl Stangl Original Article 28 April 2009 Pages: 793 - 802
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans V. CatalánJ. Gómez-AmbrosiG. Frühbeck Original Article 23 May 2009 Pages: 803 - 813
Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity Jasmin MertensRusudan BregadzeSabine Mihm Original Article Open access 27 May 2009 Pages: 815 - 824
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism Julia PerttiläKrista MerikantoVesa M. Olkkonen Original Article Open access 25 June 2009 Pages: 825 - 835